MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 116 filers reported holding MAXCYTE INC in Q2 2023. The put-call ratio across all filers is 4.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,363,584 | +76.0% | 347,853 | +88.2% | 0.00% | – |
| Q1 2024 | $774,559 | -16.5% | 184,859 | -6.4% | 0.00% | – |
| Q4 2023 | $927,912 | +62.5% | 197,428 | +7.9% | 0.00% | – |
| Q3 2023 | $571,072 | -24.8% | 183,036 | +10.7% | 0.00% | – |
| Q2 2023 | $759,035 | +13.4% | 165,367 | +22.3% | 0.00% | – |
| Q1 2023 | $669,339 | -0.3% | 135,220 | +10.0% | 0.00% | – |
| Q4 2022 | $671,253 | +22425.3% | 122,940 | -73.2% | 0.00% | -100.0% |
| Q3 2022 | $2,980 | -51.3% | 458,420 | -64.5% | 0.00% | -50.0% |
| Q2 2022 | $6,113 | -99.9% | 1,292,242 | +28.7% | 0.00% | +100.0% |
| Q1 2022 | $7,016,000 | +186.5% | 1,003,738 | +317.5% | 0.00% | – |
| Q4 2021 | $2,449,000 | +28.3% | 240,394 | +53.7% | 0.00% | – |
| Q3 2021 | $1,909,000 | – | 156,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,225,000 | $20,963,000 | 8.46% |
| NORTH RUN CAPITAL, LP | 556,960 | $3,620,000 | 7.35% |
| Vitruvian Partners LLP | 5,043,356 | $32,782,000 | 5.85% |
| Casdin Capital, LLC | 10,735,786 | $69,783,000 | 4.58% |
| RIVER GLOBAL INVESTORS LLP | 1,867,113 | $11,880,000 | 2.28% |
| APIS CAPITAL ADVISORS, LLC | 200,000 | $1,300,000 | 1.95% |
| Pier Capital, LLC | 1,262,654 | $8,207,000 | 1.41% |
| Montanaro Asset Management Ltd | 929,000 | $6,009,000 | 0.92% |
| First Light Asset Management, LLC | 1,362,543 | $8,857,000 | 0.90% |
| Grandeur Peak Global Advisors, LLC | 1,206,013 | $7,839,000 | 0.48% |